Skip to main content

Table 2 Characteristics assessed

From: Systematic reviews of observational studies of risk of thrombosis and bleeding in urological surgery (ROTBUS): introduction and methodology

Characteristics

Year of publication

Patient recruitment (first and last year)

Source of samplinga

Study typed

Country/countries

Multinational (yes/no)

Urological procedure(s)

Total number of patients

Gender distribution

Age (mean/median/threshold)

Proportion of patients with malignant disease

Use and extension of pelvic lymph node dissection

Patient use of mechanical thromboprophylaxisb

Patient use of anticoagulantse

Patient use of aspirin or other antiplatelet drugsc

Patient use of both mechanical and aspirin/anticoagulantsb,c,e

  1. aEither retrospective case series, register/administrative database, or prospective cohort study.
  2. bIncluding antithrombosis stockings, intermittent pneumatic compression devices, and foot-pumps.
  3. cIncluding aspirin, clopidogrel, dipyridamole, prasugrel, ticagrelor, ticlopidine, cilostazol, abciximab, eptifibatide, tirofiban, as well as thromboxane inhibitors, thromboxane synthase inhibitors, thromboxane receptor antagonists, and terutroban.
  4. dEither single-surgeon series; single center, not single surgeon; multicenter in one country; international multicenter.
  5. eIncluding warfarin, low molecular weight heparin, low dose unfractioned heparin, rivaroxaban, dabigatran, apixaban, fondaparinux, and idraparinux.